What is the main business of Kardiotel?

The main business activity of Kardiotel focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 24, 2006.

Where is the headquarters located?

The headquarters is located at: Jana Z Kolna 16, 81-741 Sopot.

Who is on the management board?

The management board consists of: Mikołaj Adam Orchowski (President of the Management Board) and Adam Tadeusz Orchowski (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 435,000 (approx. $117,504).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $6,094,978 in 2025, which is an increase of 13.4% compared to 2024.

Yes, the company recorded a net profit of $316,942 in 2025, meaning the company increased its profit by 893.2%.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $2,809,721 in 2025, representing 49% of all operating expenses.

Kardiotelsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2006-08-24

Share capital

435 000,00 PLN

Activity description

Kardiotel is a clinic specializing in ophthalmic procedures, including cataract surgery, laser vision correction, and treatment for keratoconus. Additionally, it provides primary healthcare services for children and adults, including family medicine and neurology, at its new location in Sopot. The clinic also offers preventive health programs and coordinated care under the National Health Fund (NFZ).

Registered address

Jana Z Kolna 16, 81-741 Sopot, Poland

Website

kardiotel.pl

Phone

Electronic delivery address

AE:PL-34474-51562-ETBBD-30

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 6.09mMedianUSD 424.39kAverageUSD 1.68m

Net profit

This companyUSD 316.94kMedianUSD 13.22kAverageUSD 129.69k

Operating costs

This companyUSD 5.75mMedianUSD 377.30kAverageUSD 1.50m

Assets

This companyUSD 1.74mMedianUSD 168.66kAverageUSD 1.47m

Industry

Bank accounts

Registered as a VAT taxpayer on 2013-03-11. Active

Erste Bank Polska
97 1500 1706 1217 0005 3610 0000
mBank
89 1140 2017 0000 4402 1304 7390

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

15 public aid cases recorded, with a total value of $241,529.

Grant date	Purpose	Gross amount	Granting body
May 21, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$18,440$18,440	Prezes Banku Gospodarstwa Krajowego
Dec 4, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$1,406$1,406	Prezes Banku Gospodarstwa Krajowego
Oct 17, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$6,895$6,895	PREZYDENT MIASTA GDAŃSK

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Kardiotel has been an NFZ healthcare provider since 2008. In 2026 it is performing 4 contracts with a total value of USD 2.65m. All its contracts were worth USD 25.64m in total.

NFZ contract value by year (in k USD)

Type of care	NFZ branch	Contracts	Value in 2026
Ambulatoryjna opieka specjalistyczna	pomorskie	1	USD 1.74m
Leczenie szpitalne	pomorskie	2	USD 853.78k
Podstawowa Opieka Zdrowotna	pomorskie	1	USD 51.17k

Regulatory authorisations

Authority	Type	Status
KNF	Consumer credit intermediary	Active
BDO	BDO register entry	Active

Authorized Representatives

Mikołaj Adam Orchowski – President of the Management Board

Adam Tadeusz Orchowski – Vice President of the Management Board

Manner of representation

Each member of the management board has the right to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Adam Tadeusz Orchowski (75)	2,262	$61,102.11	52%
Mikołaj Adam Orchowski (40)	2,088	$56,401.94	48%

Adam Tadeusz Orchowski and Mikołaj Adam Orchowski hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Nawrocki ClinicS.K.A.	$8,981,981.05	nawrockiclinic.com
Centrum Medyczne Serce Sercusp. z o.o.	$5,367,886.91	serce-sercu.pl
Przychodnia Orłowosp. z o.o.	$4,783,382.29	orlowo.com
Fudeko Medsp. z o.o.	$4,546,167.60	fudekomed.pl
Twoje ZdrowieS.A.	$4,448,668.70	twojezdrowie.pl
Euromedicussp. z o.o.	$4,179,295.20	euromedicus.pl
Centrum Medyczne Sopmedsp. z o.o.	$4,106,561.09	sopmed.pl
Mega-Lenssp. z o.o.	$3,290,632.61	megalens.pl
Medipunkt Pozsp. z o.o.	$3,147,734.16	medipunkt.pl
Mw-Medsp. z o.o.	$2,332,168.77	mwmed.pl

Change history

Date	Event
2020-03-19	PKD change (Removed: 82.20.Z, 86.23.Z, 86.90.B, 86.90.D)
2012-08-17	Share capital change (360,000.00 PLN → 435,000.00 PLN)
2012-08-17	PKD change (Removed: 22.11.Z, 22.13.Z, 22.15.Z, 33.10.B, 51.18.Z, 51.19.Z, 52.32.Z, 52.48.A, 52.63.A, 52.63.B, 55.23.Z, 63.30.A, 63.30.B, 63.30.C, 63.30.D, 64.20.C, 64.20.G, 71.34.Z, 71.40.Z, 72.10.Z, 72.22.Z, 72.30.Z, 72.40.Z, 72.60.Z, 73.10.F, 73.10.G, 74.14.A, 74.14.B, 74.30.Z, 74.40.Z, 74.85.Z, 74.86.Z, 74.87.A, 74.87.B, 80.42.B, 85.11.Z, 85.12.Z, 85.13.Z, 85.14.A, 85.14.B, 85.14.C, 85.14.D, 85.14.E, 85.14.F, 85.31.A, 85.31.B, 85.32.B, 85.32.C, 92.40.Z, 92.72.Z, 93.04.Z, 93.05.Z; Added: 47.99.Z, 72.19.Z, 77.29.Z, 82.20.Z, 85.60.Z, 86.10.Z, 86.21.Z, 86.22.Z, 86.23.Z, 86.90.A, 86.90.B, 86.90.C, 86.90.D, 86.90.E)
2009-02-04	Share capital change (200,000.00 PLN → 360,000.00 PLN)
2008-01-31	Share capital change (150,000.00 PLN → 200,000.00 PLN)

FAQ

Last updated: 2026-06-19